{"id":265,"date":"2015-05-01T12:37:56","date_gmt":"2015-05-01T03:37:56","guid":{"rendered":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/2015\/05\/01\/201426\/"},"modified":"2017-09-06T12:57:46","modified_gmt":"2017-09-06T03:57:46","slug":"201426","status":"publish","type":"post","link":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/achievement\/20150501265\/","title":{"rendered":"2014\u5e74\uff08\u5e73\u621026\u5e74\u5ea6\uff09\u306e\u7814\u7a76\u696d\u7e3e"},"content":{"rendered":"

A. \u8ad6\u6587<\/h3>\n

\u3010\u8457\u66f8\u3011<\/h4>\n

\u3010\u539f\u8457\u3011<\/h4>\n
    \n
  1. \u95a2\u826f\u4e8c, \u9577\u53cb\u5b89\u5f18, \u5c71\u53e3\u54f2\u6717, \u677e\u672c\u7d2b\u6717. \u5bae\u5d0e\u770c\u4e0b\u306b\u304a\u3051\u308b\u6210\u4eba\u5598\u606f\u60a3\u8005\u306b\u5bfe\u3057\u306610\u5e74\u9593\u9023\u7d9a\u3057\u3066\u884c\u3063\u305f\u5b9f\u614b\u8abf\u67fb \u2015\u5bae\u5d0e\u770c\u6c17\u7ba1\u652f\u5598\u606f\u30d5\u30a9\u30fc\u30e9\u30e0\u3067\u306e\u691c\u8a0e\u2015. \u30a2\u30ec\u30eb\u30ae\u30fc. 2014; 63:6, 794-804.(6\u67081\u65e5)<\/li>\n
  2. \u52a0\u6765\u6075, \u5c71\u7530\u660e\u8f1d, \u6b66\u7530\u5c55\u5e78, \u4f50\u4f2f\u88d5\u4e8c, \u6885\u6728\u4e00\u7f8e, \u5c71\u672c\u6210\u90ce, \u5ca1\u5c71\u662d\u5f66. \u8cea\u91cf\u5206\u6790\u88c5\u7f6e\uff08MALDI\u30d0\u30a4\u30aa\u30bf\u30a4\u30d1\u30fc\uff09\u3092\u7528\u3044\u305f\u9175\u6bcd\u69d8\u771f\u83cc\u540c\u5b9a\u306b\u304a\u3051\u308b\u30b5\u30f3\u30d7\u30eb\u8abf\u6574\u6cd5\u306e\u57fa\u790e\u7684\u691c\u8a0e. \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u4f1a\u8a8c. 2014; 63: 6, 9-15.(8\u6708)<\/li>\n
  3. \u9577\u53cb\u5b89\u5f18. \u81e8\u5e8a\u691c\u67fb\u6280\u5e2b\u306e\u691c\u67fb\u8aac\u660e\u30fb\u76f8\u8ac7\u306b\u671f\u5f85\u3059\u308b\u3082\u306e\uff5e\u533b\u5e2b\u306e\u7acb\u5834\u304b\u3089\uff5e. \u5bae\u81e8\u6280\u4f1a\u8a8c. 2014; 95, 81-85. (8\u6708)<\/li>\n
  4. Miyauchi S, Umekita K, Hidaka T, Umeki K, Aratake Y, Takahashi N, Sawaguchi A, Nakatake A, Morinaga I, Morishita K Okayama A. Increased plasma lactoferrin levels in leucocytapheresis therapy in patients with rheumatoid arthritis. Rheumatology (Oxford). 2014; 53(11):1966-72. ( Nov )<\/li>\n
  5. \u5c0f\u677e\u5f18\u5e78, \u5b89\u500d\u5f18\u751f, \u65ed\u5409\u96c5\u79c0, \u8fd1\u85e4\u606d\u5e73, \u4e09\u597d\u826f\u82f1, \u897f\u6751\u5f81\u61b2, \u5bae\u5185\u4fca\u4e00, \u6cb3\u91ce\u592a\u90ce, \u4e2d\u5cf6\u5b5d\u6cbb, \u576a\u5185\u62e1\u4f38, \u6709\u6751\u4fdd\u6b21, \u5ca1\u5c71\u662d\u5f66, \u7247\u5ca1\u5bdb\u7ae0. \u81e8\u5e8a\u7814\u4fee\u5236\u5ea6\u306e\u898b\u76f4\u3057\u306b\u4f34\u3046\u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\u5352\u5f8c\u81e8\u5e8a\u30d7\u30ed\u30b0\u30e9\u30e0\u306e\u5909\u66f4\u304c\u7814\u4fee\u306b\u53ca\u307c\u3057\u305f\u5f71\u97ff\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e. \u5bae\u5d0e\u770c\u533b\u5e2b\u4f1a\u533b\u5b66\u4f1a\u8a8c. 2014; 38(2), 125-131. (9\u6708)<\/li>\n
  6. \u9ad8\u57ce\u4e00\u90ce. \u533b\u7642\u95a2\u9023\u611f\u67d3 (HAI) \u5bfe\u7b56 (1) \uff5e\u7279\u306b\u5916\u6765\u3067\u306e\u91cd\u8981\u6027\uff5e. \u5bae\u5d0e\u770c\u5185\u79d1\u533b\u4f1a\u8a8c. 2014; 86: 31-34.(10\u6708)<\/li>\n
  7. \u9ad8\u57ce\u4e00\u90ce. \u533b\u7642\u95a2\u9023\u611f\u67d3 (HAI) \u5bfe\u7b56 (2) \uff5e\u611f\u67d3\u7d4c\u8def\u5225\u4e88\u9632\uff5e. \u5bae\u5d0e\u770c\u5185\u79d1\u533b\u4f1a\u8a8c. 2015; 87: 28-32. (3\u6708)<\/li>\n<\/ol>\n

    \u3010\u75c7\u4f8b\u5831\u544a\uff08\u8ad6\u6587\uff09\u3011<\/h4>\n
      \n
    1. \u5c3e\u65b9\u7f8e\u5e78, \u6238\u4e95\u7530\u73b2\u5b50, \u798f\u7530\u667a\u5b50, \u6c60\u5bae\u5229\u9999, \u6b66\u7530\u6075\u7f8e\u5b50, \u9234\u6728\u5343\u4ee3\u5b50, \u5c0f\u5c71\u5f70\u5e73, \u53e4\u7530\u8ce2, \u9b3c\u585a\u4e45\u5145, \u9db4\u7530\u654f\u535a, \u77f3\u5ddd\u54f2\u61b2, \u9bab\u5cf6\u6d69, \u5ca1\u5c71\u662d\u5f66. \u5468\u7523\u671f\u306b\u6025\u6027\u5fc3\u4e0d\u5168\u3092\u767a\u75c7\u3057\u3001\u8a3a\u65ad\u306b\u96e3\u6e0b\u3057\u305f\u5de6\u5ba4\u5fc3\u7b4b\u7dfb\u5bc6\u5316\u969c\u5bb3\u3092\u6709\u3057\u305f\u4e00\u4f8b. \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u4f1a\u8a8c. 2014; 63: 6, 41-45.(8\u6708)<\/li>\n
    2. \u6b66\u7530\u6075\u7f8e\u5b50, \u798f\u7530\u667a\u5b50, \u6238\u4e95\u7530\u73b2\u5b50,\u3000\u6c60\u5bae\u5229\u9999, \u5c3e\u65b9\u7f8e\u5e78, \u9234\u6728\u5343\u4ee3\u5b50, \u6885\u6728\u4e00\u7f8e, \u5c71\u53e3\u79c0\u6a39, \u77f3\u5ddd\u54f2\u61b2, \u4e2d\u91cc\u96c5\u5149, \u5ca1\u5c71\u662d\u5f66. \u8910\u8272\u7d30\u80de\u816b\u306b\u4f34\u3044\u9006\u305f\u3053\u3064\u307c\u578b\u306e\u4e00\u904e\u6027\u5de6\u5ba4\u58c1\u904b\u52d5\u7570\u5e38\u3092\u304d\u305f\u3057\u305f\u4e00\u75c7\u4f8b. \u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u4f1a\u8a8c. 2014; 63: 6, 46-51.(8\u6708)<\/li>\n
    3. Sakaguchi S, Nishi Keiko, Yamashita Yasuhiro, Hiratsuka Takeaki, Hara Seiichiro, Okayama A. Whiite urine due to urinary tract infection. Kidney International. 2014; 86: 655.<\/li>\n
    4. Kawaguchi T, Kariya Y, Matsuda M, Kubo K, Miyauchi S, Kusumoto N, Ueno S, Takajo I, Nagatomo Y, Tahira Y, Yamamoto S, Yorita K, Kataoka H and Okayama A. Crystalglobulinemia with Fulminant Course with Cylinder-like Bodies on Peripheral Blood Smear. Intern Med. 2014; 53: 1847-1851.<\/li>\n
    5. \u6a4b\u5834\u5f25\u751f, \u6885\u5317\u90a6\u5f66, \u4eee\u5c4b\u88d5\u7f8e, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u4e0a\u91ce\u53f2\u6717, \u6960\u5143\u898f\u751f, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66, \u6ff1\u53e3\u5112\u4eba, \u85e4\u672c\u5b66, \u77f3\u4e95\u5343\u5bf8, \u702c\u6238\u5c71\u5145. \u86cb\u767d\u6f0f\u51fa\u6027\u80c3\u8178\u75c7\u3068\u9593\u8cea\u6027\u80ba\u708e\u3092\u5408\u4f75\u3057\u305f\u6297\uff23\uff21\uff24\uff2d-140\u6297\u4f53\u967d\u6027\u306e\u76ae\u819a\u7b4b\u708e. \u4e5d\u5dde\u30ea\u30a6\u30de\u30c1. 2014; 34(2): 151-157.(9\u6708)<\/li>\n
    6. \u6960\u5143\u898f\u751f, \u9577\u53cb\u5b89\u5f18, \u5ddd\u53e3\u525b, \u4eee\u5c4b\u88d5\u7f8e, \u677e\u7530\u57fa\u5f18, \u4e45\u4fdd\u548c\u7fa9, \u5bae\u5185\u4fca\u4e00, \u4e0a\u91ce\u53f2\u6717, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u5f53\u521d\u4e2d\u8449\u7121\u6c17\u80ba\u3092\u5448\u3057\u305f\u30a2\u30ec\u30eb\u30ae\u30fc\u6027\u6c17\u7ba1\u652f\u80ba\u30a2\u30b9\u30da\u30eb\u30ae\u30eb\u30b9\u75c7\u306e1\u4f8b. \u5bae\u5d0e\u770c\u533b\u5e2b\u4f1a\u533b\u5b66\u4f1a\u8a8c. 2014; 38(2): 99-104.(9\u6708)<\/li>\n
    7. Sakaguchi S, Nishi K, Yamashita Y, Hiratsuka T, Hara S, Okayama A. \u5c3f\u8def\u611f\u67d3\u75c7\u306b\u3088\u308b\u767d\u8272\u5c3f. Kidney International Selections \u65e5\u672c\u8a9e\u7248. 2015; 13(1): 2.(1\u6708)<\/li>\n<\/ol>\n

      \u3010\u7dcf\u8aac\u3011<\/h4>\n
        \n
      1. \u5ca1\u5c71\u662d\u5f66. HTLV-1\u611f\u67d3\u3068\u81ea\u5df1\u514d\u75ab\u75be\u60a3\u306b\u304a\u3051\u308bclinical questions. \u81e8\u5e8a\u514d\u75ab\u30fb\u30a2\u30ec\u30eb\u30ae\u30fc\u79d1. 2014; 62(6):686\uff0d691. (2014\u5e7412\u670825\u65e5\u767a\u884c)<\/li>\n<\/ol>\n

        –<\/p>\n

        \n\"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a>\n<\/div>\n

        B. \u767a\u8868<\/h3>\n

        \u3010\u5b66\u4f1a\u767a\u8868\u3011<\/h4>\n
          \n
        1. \u677e\u7530\u57fa\u5f18, \u4e0a\u91ce\u53f2\u6717, \u5ddd\u53e3\u525b, \u4e45\u4fdd\u548c\u7fa9, \u5bae\u5185\u4fca\u4e00, \u6960\u5143\u898f\u751f, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u975eHIV\u75be\u60a3\u306b\u5408\u4f75\u3057\u305f\u30cb\u30e5\u30fc\u30e2\u30b7\u30b9\u30c1\u30b9\u80ba\u708e\u306e\u81e8\u5e8a\u7684\u691c\u8a0e. \u7b2c111\u56de\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u8b1b\u6f14\u4f1a. \u547c\u5438\u5668\u2463 130. 2014. (4\u670811\u65e5-13\u65e5(11\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u6771\u4eac\u56fd\u969b\u30d5\u30a9\u30fc\u30e9\u30e0)<\/li>\n
        2. \u7559\u91ce\u6587\u97f3, \u5bae\u5185\u4fca\u4e00, \u9ed2\u6728\u66a2\u4e00, \u539f\u5584\u6839, \u6cbb\u7530\u502b\u5b5d, \u5bae\u5f8c\u51b4, \u5869\u898b\u4e00\u525b, \u5ca1\u5c71\u662d\u5f66. PR3-ANCA\u9670\u6027\u3001MPO-ANCA\u967d\u6027\u306e\u591a\u767a\u8840\u7ba1\u708e\u6027\u8089\u82bd\u816b\u75c7\u306e1\u4f8b. \u7b2c111\u56de\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u8b1b\u6f14\u4f1a\u30b5\u30c6\u30e9\u30a4\u30c8\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0. \u533b\u5b66\u751f\u30fb\u7814\u4fee\u533b\u306e\u5185\u79d1\u5b66\u30b5\u30df\u30c3\u30c82014,\u3000\u30a2\u30ec\u30eb\u30ae\u30fc\u30fb\u81a0\u539f\u75c53. 2014. (4\u670812\u65e5, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u6771\u4eac\u56fd\u969b\u30d5\u30a9\u30fc\u30e9\u30e0)<\/li>\n
        3. \u6b66\u7530\u6075\u7f8e\u5b50, \u6238\u4e95\u7530\u73b2\u5b50, \u7530\u4e2d\u6d69\u559c, \u5897\u5143\u5927\u7950, \u798f\u7530\u667a\u5b50, \u9ed2\u6728\u5efa\u543e, \u5c0f\u5c71\u5f70\u5e73, \u4e95\u624b\u53e3\u6b66\u53f2, \u9b3c\u585a\u4e45\u5145, \u9db4\u7530\u654f\u535a, \u77f3\u5ddd\u54f2\u61b2, \u5ca1\u5c71\u662d\u5f66, \u5317\u6751\u548c\u96c4. \u5065\u8a3a\u3092\u5951\u6a5f\u306b\u8a3a\u65ad\u3001\u9ad8\u9f62\u767a\u75c7\u3057\u305f\u5927\u52d5\u8108\u5f01\u4e0b\u819c\u6027\u72ed\u7a84\u306e\u4e00\u4f8b. \u7b2c25\u56de\u65e5\u672c\u5fc3\u30a8\u30b3\u30fc\u56f3\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u4e00\u822c\u6f14\u984c(\u30dd\u30b9\u30bf\u30fc) \u5148\u5929\u6027\u5fc3\u75be\u60a3-1 P19-6. 2014. (4\u670817\u65e5-19\u65e5(18\u65e5\u767a\u8868\uff09, \u77f3\u5ddd\u770c\u91d1\u6ca2\u5e02, \u91d1\u6ca2\u770c\u7acb\u97f3\u697d\u5802\u3001\u91d1\u6ca2\u5e02\u30a2\u30fc\u30c8\u30db\u30fc\u30eb)<\/li>\n
        4. \u4e45\u4fdd\u548c\u7fa9, \u5bae\u5185\u4fca\u4e00 \u6885\u5317\u90a6\u5f66, \u6ff1\u7530\u6d69\u6717, \u5ca1\u5c71\u662d\u5f66 \u5e16\u4f50\u60a6\u7537. \u5bae\u5d0e\u770c\u306b\u304a\u3051\u308b\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u5bfe\u3059\u308b\u751f\u7269\u5b66\u7684\u88fd\u5264\u306e\u4f7f\u7528\u5b9f\u614b\u8abf\u67fb(\u7b2c3\u5831). \u7b2c58\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. PS1-5 \u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306e\u6cbb\u7642\uff1a\u751f\u7269\u5b66\u7684\u88fd\u5264(\uff34\uff2e\uff26\u963b\u5bb3\u85ac)1, P1-044. 2014. (4\u670824\u65e5-26\u65e5(24\u65e5\u767a\u8868) , \u6771\u4eac\u90fd\u6e2f\u533a, \u30b0\u30e9\u30f3\u30c9\u30d7\u30ea\u30f3\u30b9\u30db\u30c6\u30eb\u65b0\u9ad8\u8f2a, \u56fd\u969b\u9928\u30d1\u30df\u30fc\u30eb)<\/li>\n
        5. \u7532\u6590\u6cf0\u6587, \u65e5\u9ad8\u5229\u5f66, \u6a4b\u5834\u5f25\u751f, \u9ed2\u7530\u5b8f. \u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u5bfe\u3059\u308b\uff23\uff45\uff52\uff54\uff4f\uff4c\uff49\uff5a\uff55\uff4d\uff41\uff42\u3000\uff30\uff45\uff47\uff4f\uff4c\u56fd\u5185\u81e8\u5e8a\u8a66\u9a13\u7d42\u4e86\u5f8c\u306e\u5f53\u9662\u75c7\u4f8b\u306e\u4e2d\u9593\u5831\u544a. \u7b2c58\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. PS2-10 \u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306e\u6cbb\u7642\uff1a\u751f\u7269\u5b66\u7684\u88fd\u5264(\uff34\uff2e\uff26\u963b\u5bb3\u85ac)2, P2-114. 2014. (4\u670824\u65e5-26\u65e5(25\u65e5\u767a\u8868) , \u6771\u4eac\u90fd\u6e2f\u533a, \u30b0\u30e9\u30f3\u30c9\u30d7\u30ea\u30f3\u30b9\u30db\u30c6\u30eb\u65b0\u9ad8\u8f2a, \u56fd\u969b\u9928\u30d1\u30df\u30fc\u30eb)<\/li>\n
        6. \u6a4b\u5834\u5f25\u751f, \u7532\u6590\u6cf0\u6587, \u9ed2\u7530\u5b8f, \u65e5\u9ad8\u5229\u5f66. \u5f53\u9662\u3067\u306e\u30c8\u30b7\u30ea\u30ba\u30de\u30d6\u70b9\u6ef4\u88fd\u5264\u304b\u3089\u76ae\u4e0b\u88fd\u5264\u3078\u306e\u5207\u66ff\u3048\u306b\u95a2\u3059\u308b\u4e8b\u524d\u30a2\u30f3\u30b1\u30fc\u30c8\u8abf\u67fb\u53ca\u3073\u76ae\u4e0b\u88fd\u5264\u5207\u66ff\u3048\u5f8c\u306e\u6cbb\u7642\u52b9\u679c\u306b\u3064\u3044\u3066. \u7b2c58\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. PS2-10 \u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306e\u6cbb\u7642\uff1a\u751f\u7269\u5b66\u7684\u88fd\u5264(\uff34\uff2e\uff26\u963b\u5bb3\u85ac)2, P2-135. 2014. (4\u670824\u65e5-26\u65e5(25\u65e5\u767a\u8868) , \u6771\u4eac\u90fd\u6e2f\u533a, \u30b0\u30e9\u30f3\u30c9\u30d7\u30ea\u30f3\u30b9\u30db\u30c6\u30eb\u65b0\u9ad8\u8f2a, \u56fd\u969b\u9928\u30d1\u30df\u30fc\u30eb)<\/li>\n
        7. \u5ddd\u53e3\u525b, \u4eee\u5c4b\u88d5\u7f8e, \u677e\u7530\u57fa\u5f18, \u4e45\u4fdd\u548c\u7fa9, \u5bae\u5185\u4fca\u4e00, \u6960\u5143\u898f\u751f, \u4e0a\u91ce\u53f2\u6717, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u76f4\u8178\u30fb\u809b\u9580\u90e8\u6f70\u760d\u3092\u5448\u3057\u305f\u8178\u7ba1\u30d9\u30fc\u30c1\u30a7\u30c3\u30c8\u75c5\u306e\u307e\u3068\u3081\u3001\u81ea\u9a13\u4f8b2\u4f8b\u3092\u542b\u3081\u305f\u672c\u90a6\u5831\u544a\u4f8b24\u4f8b\u306e\u6587\u732e\u7684\u8003\u5bdf. \u7b2c58\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. PS3-21 \u30d9\u30fc\u30c1\u30a7\u30c3\u30c8\u75c5, P2-271. 2014. (4\u670824\u65e5-26\u65e5(25\u65e5\u767a\u8868) , \u6771\u4eac\u90fd\u6e2f\u533a, \u30b0\u30e9\u30f3\u30c9\u30d7\u30ea\u30f3\u30b9\u30db\u30c6\u30eb\u65b0\u9ad8\u8f2a, \u56fd\u969b\u9928\u30d1\u30df\u30fc\u30eb)<\/li>\n
        8. \u65e5\u9ad8\u5229\u5f66, \u6a4b\u5834\u5f25\u751f, \u7532\u6590\u6cf0\u6587, \u9ed2\u7530\u5b8f. \u5f53\u9662\u306b\u304a\u3051\u308b\u81a0\u539f\u75c5\u60a3\u8005\u306b\u5bfe\u3059\u308b\u80c3\u98df\u9053\u9006\u6d41\u75c7(\uff27\uff25\uff32\uff24)\u5b9f\u614b\u8abf\u67fb\u7d50\u679c. \u7b2c58\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. PS2-21 \u7dda\u7dad\u7b4b\u75db\u75c7\u30fb\u81e8\u5e8a(\u5185\u79d1)\u30fb\u8840\u6db2\u6d44\u5316\u7642\u6cd53, P3-284. 2014. (4\u670824\u65e5-26\u65e5(26\u65e5\u767a\u8868) , \u6771\u4eac\u90fd\u6e2f\u533a, \u30b0\u30e9\u30f3\u30c9\u30d7\u30ea\u30f3\u30b9\u30db\u30c6\u30eb\u65b0\u9ad8\u8f2a, \u56fd\u969b\u9928\u30d1\u30df\u30fc\u30eb)<\/li>\n
        9. \u65e5\u9ad8\u5229\u5f66, \u6a4b\u5834\u5f25\u751f, \u7532\u6590\u6cf0\u6587, \u9ed2\u7530\u5b8f. \u30a2\u30c0\u30ea\u30e0\u30de\u30d6\u306b\u3088\u308b\u5bdb\u89e3\u4f11\u85ac\u7dad\u6301\u3092\u53ef\u80fd\u3068\u3059\u308b\u6761\u4ef6\u306e\u691c\u8a0e. \u7b2c58\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. W25 \u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306e\u6cbb\u7642\uff1a\u751f\u7269\u5b66\u7684\u88fd\u5264(\uff34\uff2e\uff26\u963b\u5bb3\u85ac)5, W25-6. 2014. (4\u670824\u65e5-26\u65e5(25\u65e5\u767a\u8868) , \u6771\u4eac\u90fd\u6e2f\u533a, \u30b0\u30e9\u30f3\u30c9\u30d7\u30ea\u30f3\u30b9\u30db\u30c6\u30eb\u65b0\u9ad8\u8f2a, \u56fd\u969b\u9928\u30d1\u30df\u30fc\u30eb)<\/li>\n
        10. \u65e5\u9ad8\u5229\u5f66, \u6a4b\u5834\u5f25\u751f, \u7532\u6590\u6cf0\u6587, \u9ed2\u7530\u5b8f. \u5f53\u9662\u306b\u304a\u3044\u3066\u767d\u8840\u7403\u9664\u53bb\u7642\u6cd5\u3092\u65bd\u884c\u3057\u305f\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u60a3\u8005\u306e\u9577\u671f\u30a2\u30a6\u30c8\u30ab\u30e0. \u7b2c58\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. W79 \u7dda\u7dad\u7b4b\u75db\u75c7\u30fb\u81e8\u5e8a(\u5185\u79d1)\u30fb\u8840\u6db2\u6d44\u5316\u7642\u6cd52, W79-4. 2014. (4\u670824\u65e5-26\u65e5(26\u65e5\u767a\u8868) , \u6771\u4eac\u90fd\u6e2f\u533a, \u30b0\u30e9\u30f3\u30c9\u30d7\u30ea\u30f3\u30b9\u30db\u30c6\u30eb\u65b0\u9ad8\u8f2a, \u56fd\u969b\u9928\u30d1\u30df\u30fc\u30eb)<\/li>\n
        11. \u677e\u7530\u57fa\u5f18, \u4e0a\u91ce\u53f2\u6717, \u5ddd\u53e3\u525b, \u4e45\u4fdd\u548c\u7fa9, \u5bae\u5185\u4fca\u4e00, \u6960\u5143\u898f\u751f, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u751f\u7269\u5b66\u7684\u88fd\u5264\u6295\u4e0e\u4e2d\u306e\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u60a3\u8005\u306b\u51fa\u73fe\u3057\u305f\u547c\u5438\u5668\u75be\u60a3\u306e\u81e8\u5e8a\u7684\u691c\u8a0e. \u7b2c54\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a. \u81a0\u539f\u75c5\u95a2\u9023\u80ba\u75be\u60a3 1, PP116. 2014. (4\u670825\u65e5-27\u65e5(25\u65e5\u767a\u8868), \u5927\u962a\u5e9c\u5927\u962a\u5e02, \u5927\u962a\u56fd\u969b\u4f1a\u8b70\u5834\u30fb\u30ea\u30fc\u30ac\u30ed\u30a4\u30e4\u30eb\u30db\u30c6\u30eb)<\/li>\n
        12. \u5e73\u585a\u96c4\u8061, \u5742\u53e3\u7fd4\u592a, \u65e9\u5ddd\u5b66, \u98db\u677e\u6b63\u6a39, \u677e\u7530\u4fca\u592a\u90ce, \u897f\u6842\u5b50, \u690e\u5c4b\u667a\u7f8e, \u539f\u8aa0\u4e00\u90ce, \u5927\u7aaa\u5d07\u4e4b, \u897f\u5e73\u8ce2\u4f5c. \u6570\u5e74\u306e\u7d4c\u904e\u3067\u80ba\u9580\u304b\u3089\u8f2a\u72b6\u306b\u62e1\u5927\u3059\u308b\u9670\u5f71\u3092\u5448\u3057\u305f\u80ba\u7d50\u6838\u306e1\u4f8b. \u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u4e3b\u50ac \u7b2c305\u56de\u4e5d\u5dde\u5730\u65b9\u4f1a. \u547c\u5438\u56682 71. 2014. (5\u670831\u65e5, \u718a\u672c\u770c\u718a\u672c\u5e02, \u304f\u307e\u3082\u3068\u68ee\u90fd\u5fc3\u30d7\u30e9\u30b6\u30db\u30fc\u30eb)<\/li>\n
        13. \u9ad8\u57ce\u4e00\u90ce, \u6960\u5143\u898f\u751f, \u5ca1\u5c71\u662d\u5f66. \u5c4a\u3051\u51fa\u5236\u306b\u57fa\u3065\u3044\u305f\u30c0\u30d7\u30c8\u30de\u30a4\u30b7\u30f3\u306e\u4f7f\u7528\u72b6\u6cc1\u306e\u691c\u8a0e. \u7b2c88\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a \u7b2c62\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a \u5408\u540c\u5b66\u4f1a. \u611f P1-167. 2014. \uff086\u670818\u65e5-20\u65e5(18\u65e5\u767a\u8868), \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u30d2\u30eb\u30c8\u30f3\u798f\u5ca1\u30b7\u30fc\u30db\u30fc\u30af)<\/li>\n
        14. \u5e73\u539f\u5eb7\u5bff, \u9ad8\u57ce\u4e00\u90ce. \u6297\u83cc\u85ac\u9069\u6b63\u4f7f\u7528\u306b\u304a\u3051\u308bTDM\u5b9f\u65bd\u7387\u5411\u4e0a\u306b\u5411\u3051\u305f\u53d6\u7d44\u307f. \u7b2c88\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a \u7b2c62\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a \u5408\u540c\u5b66\u4f1a. \u5316 P1-149. 2014. (6\u670818\u65e5-20\u65e5(18\u65e5\u767a\u8868), \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u30d2\u30eb\u30c8\u30f3\u798f\u5ca1\u30b7\u30fc\u30db\u30fc\u30af)<\/li>\n
        15. \u6960\u5143\u898f\u751f, \u5ddd\u53e3\u525b, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u4e0a\u91ce\u53f2\u6717, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u5f53\u9662\u306b\u304a\u3051\u308b\uff28\uff29\uff36\/\uff21\uff29\uff24\uff33\u8a3a\u7642\u306e\u73fe\u72b6. \u7b2c88\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a \u7b2c6\uff12\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a \u5408\u540c\u5b66\u4f1a. \u611f \uff302-002. 2014. (6\u670818\u65e5-20\u65e5(19\u65e5\u767a\u8868), \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u30d2\u30eb\u30c8\u30f3\u798f\u5ca1\u30b7\u30fc\u30db\u30fc\u30af)<\/li>\n
        16. Umekita K, M Trenkmann, C Kolling, B Michel, R Gay, S Gay, M Frank Bertoncelj. THE FEEDBACK\u3000LOOP BETWEEN LONG NONCODING RNA NRON AND NFAT5 REGULATES THE INFLAMMATORY RESPONSE OF RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLASTS. Annual European Congress of RHEUMATOLOGY\u3000EULAR 2014. FRI0351. 2014. (June 11-14(13presentation), Paris France, Le Palais des Congres de Paris)<\/li>\n
        17. Miyauchi S, Umekita K, Kawaguchi T, Sakaguchi S, Kariya Y, Hashiba Y, Matsuda M, Kubo K, Hidaka T, Umeki K, Aratake Y, Takahashi N, Sawaguchi A, Nakatake A, Morinaga I, Morishita K, Okayama A. INCREASED PLASMA LACTOFERRIN LEVELS IN LEUKOCYTAPHERESIS THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS. Annual European Congress of RHEUMATOLOGY\u3000EULAR 2014. AB0475. 2014. (June 11-14, Paris France, Le Palais des Congres de Paris)<\/li>\n
        18. \u6960\u5143\u898f\u751f, \u9577\u53cb\u5b89\u5f18, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u5ca1\u5c71\u662d\u5f66, \u4e0a\u904b\u5929\u7dbe\u5b50, \u65e5\u9ad8\u667a\u5fb3, \u5317\u4e2d\u660e, \u4e0b\u7530\u548c\u54c9. \u80ba\u539f\u767a\u52a0\u9f62\u6027EBV\u967d\u6027\u3073\u307e\u3093\u6027\u5927\u7d30\u80de\u578bB\u7d30\u80de\u30ea\u30f3\u30d1\u816b. \u7b2c12\u56de\u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. P3-17 \u547c\u5438\u5668 14, P3-17-6. 2014. (7\u670817\u65e5-19\u65e5(19\u65e5\u767a\u8868), \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u798f\u5ca1\u56fd\u969b\u30bb\u30f3\u30bf\u30fc)<\/li>\n
        19. \u6885\u6728\u4e00\u7f8e, \u6a4b\u5009\u60a0\u8f1d, \u5c71\u672c\u6210\u90ce, \u5ca1\u5c71\u662d\u5f66. \u9ad8\u611f\u5ea6PCR\u6cd5\u304a\u3088\u3073Line Immunoassy\u306b\u3088\u308bHTLV-1\u6297\u4f53\u967d\u6027\u306e\u78ba\u8a8d. \u7b2c1\u56de\u65e5\u672cHTLV-\uff11\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. Session 3 \u81e8\u5e8a\u691c\u67fb\u30fb\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fcO-17. 2014. (8\u670822\u65e5-24\u65e5\uff0823\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u6e2f\u533a, \u6771\u4eac\u5927\u5b66\u533b\u79d1\u5b66\u7814\u7a76\u62401\u53f7\u9928\u8b1b\u5802)<\/li>\n
        20. \u6a4b\u5009\u60a0\u8f1d, \u6885\u6728\u4e00\u7f8e, \u5c71\u672c\u6210\u90ce,\u3000\u9577\u8c37\u5ddd\u5bdb\u96c4, \u67f3\u539f\u514b\u7d00, \u5ca1\u5c71\u662d\u5f66. MT-2\u7d30\u80de\u682a\u306eHTLV-1\u30d7\u30ed\u30a6\u30a4\u30eb\u30b9\u306e\u7d44\u307f\u8fbc\u307f\u90e8\u4f4d\u304a\u3088\u3073\u5185\u90e8\u69cb\u9020\u306e\u591a\u69d8\u6027. \u7b2c1\u56de\u65e5\u672cHTLV-\uff11\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. P-14. 2014. (8\u670822\u65e5-24\u65e5\uff0824\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u6e2f\u533a, \u6771\u4eac\u5927\u5b66\u533b\u79d1\u5b66\u7814\u7a76\u62401\u53f7\u9928\u8b1b\u5802)<\/li>\n
        21. \u8352\u6b66\u516b\u8d77, \u6e05\u5c71\u548c\u662d, \u767d\u6ff1\u5e78\u751f, \u67cf\u7530\u5948\u83dc, \u5e16\u4f50\u5ba3\u662d, \u6d25\u5b88\u4f38\u4e00\u90ce, \u7dd2\u65b9\u514b\u5df1, \u5c71\u4e0b\u7be4, \u7560\u5c71\u91d1\u592a, \u6885\u6728\u4e00\u7f8e, \u91ce\u6751\u5275, \u5ca1\u5c71\u662d\u5f66, \u5357\u5d8b\u6d0b\u4e00, \u6817\u6797\u5fe0\u4fe1. \u80f8\u6c34\u4e2d\u7d30\u80de\u3088\u308a\u682a\u4fa1\u3057\u305fMerkel\u7d30\u80de\u764c\u306e\u7d30\u80de\u5b66\u7684\u7279\u5fb4. \u65e5\u672c\u30d2\u30c8\u7d30\u80de\u5b66\u4f1a\u3000\u5b66\u8853\u96c6\u4f1a\u7b2c32\u56de. \u4e00\u822c\u6f14\u984c\u3000\u53e3\u6f14 \uff62\u7d30\u80de\u682a\u306e\u6a39\u7acb\u3001\u30a6\u30a4\u30eb\u30b9\u767a\u764c\uff63. 2014. (8\u670830\u65e5-31\u65e5\uff0830\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u6e2f\u533a, \u6771\u4eac\u6148\u6075\u533b\u79d1\u5927\u5b661\u53f7\u9928)<\/li>\n
        22. \u65e5\u9ad8\u5229\u5f66, \u5742\u53e3\u7fd4\u592a, \u897f\u82f1\u5b50, \u7532\u6590\u6cf0\u6587, \u677e\u672c\u4eae, \u9ed2\u7530\u5b8f, \u6ff1\u7802\u91cd\u4ec1,\u3000\u6a4b\u5834\u5f25\u751f, \u4e45\u4fdd\u548c\u7fa9, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u80ba\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u75c7(\u80baNTM\u75c7)\u3092\u5408\u4f75\u3059\u308b\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1(RA)\u60a3\u8005\u306b\u5bfe\u3059\u308b\u6cbb\u7642\u3092\u8003\u3048\u308b. \u7b2c48\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. S-1-20. 2014. (9\u67086\u65e5-7\u65e5\uff087\u65e5\u767a\u8868\uff09, \u798f\u5ca1\u770c\u4e45\u7559\u7c73\u5e02, \u77f3\u6a4b\u6587\u5316\u30bb\u30f3\u30bf\u30fc)<\/li>\n
        23. \u6cb3\u91ce\u5f69\u5b50, \u4e45\u4fdd\u548c\u7fa9, \u4eee\u5c4b\u88d5\u7f8e, \u6a4b\u5834\u5f25\u751f, \u677e\u7530\u57fa\u5f18, \u9ad8\u57ce\u4f73\u4eba\u5b50,\u3000\u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u6960\u5143\u898f\u751f, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. CMV\u6297\u539f\u8840\u75c7\u9670\u6027\u5f8c\u306b\u3001\u80c3\u6f70\u760d\u751f\u691c\u3067CMV\u611f\u67d3\u304c\u78ba\u8a8d\u3055\u308c\u305f\u7d50\u7bc0\u6027\u591a\u767a\u52d5\u8108\u708e(PN). \u7b2c48\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u30dd\u30b9\u30bf\u30fc\u30bb\u30c3\u30b7\u30e7\u30f32 \uff62\u8840\u7ba1\u708e\u306e\u75c7\u4f8b\uff63\u3000P-2-4. 2014. (9\u67086\u65e5-7\u65e5\uff087\u65e5\u767a\u8868\uff09, \u798f\u5ca1\u770c\u4e45\u7559\u7c73\u5e02, \u77f3\u6a4b\u6587\u5316\u30bb\u30f3\u30bf\u30fc)<\/li>\n
        24. \u5742\u53e3\u7fd4\u592a, \u7532\u6590\u6cf0\u6587, \u897f\u82f1\u5b50, \u9ed2\u7530\u5b8f, \u65e5\u9ad8\u5229\u5f66. \u5f53\u9662\u306b\u304a\u3051\u308b\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u60a3\u8005\u306e\u598a\u5a20\u30fb\u51fa\u7523\u306b\u3064\u3044\u3066\u306e\u8003\u5bdf. \u7b2c48\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u30dd\u30b9\u30bf\u30fc\u30bb\u30c3\u30b7\u30e7\u30f34 \uff62RA\u95a2\u9023\u306e\u75c5\u614b\u30fb\u75c7\u4f8b\uff63\u3000P-4-8. 2014. (9\u67086\u65e5-7\u65e5\uff087\u65e5\u767a\u8868\uff09, \u798f\u5ca1\u770c\u4e45\u7559\u7c73\u5e02, \u77f3\u6a4b\u6587\u5316\u30bb\u30f3\u30bf\u30fc)<\/li>\n
        25. \u5c0f\u6751\u771f\u592e, \u677e\u7530\u57fa\u5f18, \u6a4b\u5834\u5f25\u751f, \u5bae\u5185\u4fca\u4e00, \u6960\u5143\u898f\u751f, \u9577\u53cb\u5b89\u5f18, \u5c0f\u5ba4\u5eb7\u7537. \u30de\u30af\u30ed\u30b0\u30ed\u30d6\u30ea\u30f3\u8840\u75c7\u3092\u4f34\u3063\u305fMALT\u30ea\u30f3\u30d1\u816b\u306e\u4e00\u4f8b. \u7b2c73\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u30fb\u65e5\u672c\u7d50\u6838\u75c5\u5b66\u4f1a\u30fb\u65e5\u672c\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\/\u8089\u82bd\u816b\u6027\u75be\u60a3\u5b66\u4f1a \u4e5d\u5dde\u652f\u90e8 \u79cb\u5b63\u5b66\u8853\u8b1b\u6f14\u4f1a. \u80ba\u816b\u760d 2, 8. 2014. (10\u670810\u65e5-11\u65e5\uff0810\u65e5\u767a\u8868\uff09, \u9e7f\u5150\u5cf6\u770c\u9e7f\u5150\u5cf6\u5e02, \u9e7f\u5150\u5cf6\u770c\u533b\u5e2b\u4f1a\u9928, \u9e7f\u5150\u5cf6\u5e02\u52e4\u52b4\u8005\u4ea4\u6d41\u30bb\u30f3\u30bf\u30fc)<\/li>\n
        26. \u5ddd\u53e3\u525b, \u4eee\u5c4b\u88d5\u7f8e, \u677e\u7530\u57fa\u5f18, \u6a4b\u5834\u5f25\u751f, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u6960\u5143\u898f\u751f, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u91cd\u75c7\u71b1\u6027\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7\u306e\u5bae\u5d0e\u770c\u5185\u767a\u75c7\u4f8b\u306e\u307e\u3068\u3081. \u7b2c62\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a \u7b2c57\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u4e2d\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c84\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a. \u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c72, 027. 2014. (10\u670823\u65e5-25\u65e5\uff0823\u65e5\u767a\u8868\uff09, \u5ca1\u5c71\u770c\u5ca1\u5c71\u5e02, \u5ca1\u5c71\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc)<\/li>\n
        27. \u677e\u7530\u57fa\u5f18, \u9ad8\u57ce\u4e00\u90ce, \u5ddd\u53e3\u525b, \u4eee\u5c4b\u88d5\u7f8e, \u6a4b\u5834\u5f25\u751f, \u5bae\u5185\u4fca\u4e00, \u6960\u5143\u898f\u751f, \u6885\u5317\u90a6\u5f66, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66, \u767d\u5c3e\u82f1\u4ec1. \u30c1\u30b2\u30b5\u30a4\u30af\u30ea\u30f3\u6295\u4e0e\u304c\u6709\u52b9\u3067\u3042\u3063\u305f\u591a\u5264\u8010\u6027\u30a2\u30b7\u30cd\u30c8\u30d0\u30af\u30bf\u30fc\u611f\u67d3\u75c7\u306e\u4e00\u4f8b. \u7b2c62\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a \u7b2c57\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u4e2d\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c84\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a. \u7d30\u83cc\u611f\u67d3\u75c7 1, 074. 2014. (10\u670823\u65e5-25\u65e5\uff0824\u65e5\u767a\u8868\uff09, \u5ca1\u5c71\u770c\u5ca1\u5c71\u5e02, \u5ca1\u5c71\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc)<\/li>\n
        28. \u5742\u53e3\u7fd4\u592a, \u5e73\u585a\u96c4\u8061, \u5ca1\u5c71\u662d\u5f66. \u672b\u68a2\u8840\u30ae\u30e0\u30b6\u67d3\u8272\u306b\u3066\u53cc\u7403\u83cc\u3092\u8a8d\u3081\u305f\u4fb5\u8972\u6027\u80ba\u708e\u7403\u83cc\u611f\u67d3\u75c7. \u7b2c62\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a \u7b2c57\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u4e2d\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c84\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a. \u4fb5\u8972\u6027\u80ba\u708e\u7403\u83cc\u611f\u67d3\u75c7 240. 2014. (10\u670823\u65e5-25\u65e5\uff0825\u65e5\u767a\u8868\uff09, \u5ca1\u5c71\u770c\u5ca1\u5c71\u5e02, \u5ca1\u5c71\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc)<\/li>\n
        29. Kawaguchi T, Matsuda M, Takajo I, Okayama A. Severe fever with thrombocytopenia syndrome in Miyazaki, Japan. IMED 2014. Poster Presentations \u2160 Session22.156. 2014. (Oct 31- Nov 3 (1presentation), Vienna, Hilton Vienna)<\/li>\n
        30. Takajo I, Kawaguchi T, Matsuda M, Okayama A. Clinical analysis of Helicobacter cinaedi bacteremia in patients with rheumatic diseases. IMED 2014. Poster Presentations \u2161 Session23.060. 2014. (Oct 31- Nov 3 (2presentation), Vienna, Hilton Vienna)<\/li>\n
        31. Umekita K, Trenkmann M, Kolling C, Okayama A, Gay R, Steffen Gay S, Bertoncelj MF. Long Noncoding RNA Nron Regulates the Activity of NFAT5 through\u3000Ubiquitin-Independent Proteasome Pathway in Rheumatoid Arthritis. 2014 ACR\/ARHP ANNUAL MEETING. Session: Genetics, Genomics and Proteomics I. 2014. (November 14-19(16presentation), Boston Convention & Exhibition Center, Boston, MA)<\/li>\n
        32. Okayama A, Iwanaga M, Sagara Y, Hidaka T, Umekita K, Nakano K, Watanabe T, Yamano Y, Horai Y, Nakamura H, Kawakami A. Human T-Lymphotropic Virus Type 1 Biomarkers in Patients with Rheumatoid Arthritis. 2014 ACR\/ARHP ANNUAL MEETING. Session: Infections, Infection-related Biomarkers and Impact of Biologic Therapies. 2014. (November 14-19(18presentation), Boston Convention & Exhibition Center, Boston, MA)<\/li>\n
        33. \u5c71\u7530\u660e\u8f1d, \u52a0\u6765\u6075, \u5f13\u524a\u3081\u3050\u307f, \u6b66\u7530\u5c55\u5e78, \u4f50\u4f2f\u88d5\u4e8c, \u6885\u6728\u4e00\u7f8e, \u5c71\u672c\u6210\u90ce, \u5ca1\u5c71\u662d\u5f66. \u8cea\u91cf\u5206\u6790\u88c5\u7f6e\u3092\u7528\u3044\u305f\u7cf8\u72b6\u83cc\u540c\u5b9a\u691c\u67fb\u306e\u6709\u7528\u6027\u306b\u3064\u3044\u3066. \u5e73\u621026\u5e74\u5ea6\u65e5\u81e8\u6280\u4e5d\u5dde\u652f\u90e8\u533b\u5b66\u691c\u67fb\u5b66\u4f1a(\u7b2c49\u56de). \u4e00\u822c\u6f14\u984c \u5fae\u751f\u7269 049. 2014. (11\u67081\u65e5-2\u65e5\uff082\u65e5\u767a\u8868\uff09, \u6c96\u7e04\u770c\u5b9c\u91ce\u6e7e\u5e02, \u6c96\u7e04\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc)<\/li>\n
        34. \u9ad8\u6728\u899a, \u660e\u5229\u7f8e\u91cc, \u6a4b\u5009\u60a0\u8f1d, \u4e95\u4e0a\u6b66\u5fd7, \u6885\u6728\u4e00\u7f8e, \u5c71\u672c\u6210\u90ce, \u4e45\u5bcc\u6728\u5eb8\u5b50, \u5ca1\u5c71\u662d\u5f66. \u5f53\u9662\u3067\u7d4c\u9a13\u3057\u305f\u7a00\u306a\u907a\u4f1d\u5b50\u7570\u5e38e19a2\u3092\u6709\u3059\u308b\u6162\u6027\u9aa8\u9ac4\u6027\u767d\u8840\u75c5. \u5e73\u621026\u5e74\u5ea6\u65e5\u81e8\u6280\u4e5d\u5dde\u652f\u90e8\u533b\u5b66\u691c\u67fb\u5b66\u4f1a(\u7b2c49\u56de). \u4e00\u822c\u6f14\u984c \u8840\u6db2 082. 2014. (11\u67081\u65e5-2\u65e5\uff082\u65e5\u767a\u8868\uff09, \u6c96\u7e04\u770c\u5b9c\u91ce\u6e7e\u5e02, \u6c96\u7e04\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc)<\/li>\n
        35. \u6885\u6728\u4e00\u7f8e, \u6a4b\u5009\u60a0\u8f1d, \u5c71\u672c\u6210\u90ce,\u3000\u5ca1\u5c71\u662d\u5f66. HTLV-1\u6297\u4f53\u78ba\u8a8d\u8a66\u9a13\u3068\u3057\u3066\u306eLine Immunoassay\u306e\u6709\u7528\u6027. \u7b2c61\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u4e00\u822c\u6f14\u984c \u611f\u67d3\u75c7\u2461 224. 2014. (11\u670822\u65e5-25\u65e5\uff0824\u65e5\u767a\u8868\uff09, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u798f\u5ca1\u56fd\u969b\u4f1a\u8b70\u5834)<\/li>\n
        36. \u5c71\u672c\u6210\u90ce, \u6a4b\u5009\u60a0\u8f1d, \u6885\u6728\u4e00\u7f8e, \u843d\u5408\u79c0\u4fe1, \u5ca1\u5c71\u662d\u5f66. \u81e8\u5e8a\u691c\u67fb\u6280\u5e2b\u3068\u707d\u5bb3\u652f\u63f4. \u7b2c61\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u4e00\u822c\u6f14\u984c \u30c1\u30fc\u30e0\u533b\u7642\u30fb\u75c5\u9662\u5185\u6d3b\u52d5\u3078\u306e\u8ca2\u732e\u2461 272. 2014. (11\u670822\u65e5-24\u65e5\uff0824\u65e5\u767a\u8868\uff09, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u798f\u5ca1\u56fd\u969b\u4f1a\u8b70\u5834)<\/li>\n
        37. \u5ca1\u5c71\u662d\u5f66. \u591a\u5c90\u306b\u308f\u305f\u308b\u50cd\u304d\u304b\u3051\u304c\u5fc5\u8981\u3068\u3055\u308c\u308b\u611f\u67d3\u5bfe\u7b56\u306e\u73fe\u72b6. \u7b2c61\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u30b7\u30f3\u30dd\u30b8\u30a6\u30e02. \u611f\u67d3\u5236\u5fa1\u3068\u5fae\u751f\u7269\u691c\u67fb. 2014. (11\u670822\u65e5-24\u65e5\uff0823\u65e5\u767a\u8868\uff09, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u798f\u5ca1\u56fd\u969b\u4f1a\u8b70\u5834)<\/li>\n
        38. \u677e\u5c3e\u502b\u5b50, \u677e\u7530\u57fa\u5f18, \u6cb3\u91ce\u5f69\u5b50, \u6a4b\u5834\u5f25\u751f, \u4e45\u4fdd\u548c\u7fa9, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u6960\u5143\u898f\u751f, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u521d\u8a3a\u6642\u7d05\u6591\u304c\u306a\u304f\u3001\u8a3a\u65ad\u306b\u82e6\u616e\u3057\u305f\u65e5\u672c\u7d05\u6591\u71b1. \u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u4e3b\u50ac \u7b2c308\u56de\u4e5d\u5dde\u5730\u65b9\u4f1a. \u521d\u671f\u7814\u4fee\u533b 3, 22. 2015. (1\u670810\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8\u767e\u5e74\u8b1b\u5802)<\/li>\n
        39. \u798f\u7530\u771f\u5f13, \u5ca1\u5c71\u662d\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u4f50\u4f2f\u88d5\u4e8c, \u5e73\u539f\u5eb7\u5bff. \u5f53\u9662\u306b\u304a\u3051\u308b\u904e\u53bb10\u5e74\u9593\u306e\u91dd\u523a\u3057\u5207\u5275\u3001\u76ae\u819a\u7c98\u819c\u66dd\u9732\u4e8b\u6545\u306e\u5206\u6790\u3068\u4eca\u5f8c\u306e\u8ab2\u984c. \u7b2c30\u56de\u65e5\u672c\u74b0\u5883\u611f\u67d3\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. \u91dd\u523a\u3057\u5207\u5275\u30fb\u7c98\u819c\u76ae\u819a\u66dd\u97322\u30001-P26-7. 2015. (2\u670820\u65e5-21\u65e5\uff0820\u65e5\u767a\u8868\uff09, \u5175\u5eab\u770c\u795e\u6238\u5e02, \u795e\u6238\u56fd\u969b\u5c55\u793a\u5834\u30fb\u795e\u6238\u56fd\u969b\u4f1a\u8b70\u5834\u30fb\u795e\u6238\u30dd\u30fc\u30c8\u30d4\u30a2\u30db\u30c6\u30eb)<\/li>\n
        40. Aratake Y, Nomura H, Kiyoyama K, Shirahama Y, Kashiwada N, Hayashi T, Toshimori H, Okayama A, Minamishima Y, Kuribayashi T. Expression of CD26\/DPP (Dipeptidyl peptidase \u2163) in rat thyroid lesions induced by diisopropanolnitrosamine (DIPN)The 7th Japan, Taiwan, Korea Cytotechnology Joint Meeting. March 21, 2015. Kyusyu University College of Medicine, Collabo-Station \u2160, Fukuoka.<\/li>\n
        41. \u4e45\u4fdd\u548c\u7fa9, \u6cb3\u91ce\u5f69\u5b50, \u4eee\u5c4b\u88d5\u7f8e, \u6a4b\u5834\u5f25\u751f, \u677e\u7530\u57fa\u5f18, \u9ad8\u57ce\u4f73\u4eba\u5b50, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u6960\u5143\u898f\u751f, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u732a\u4fe3\u5c1a\u898f, \u6ff1\u7530\u6d69\u6717, \u5ca1\u5c71\u662d\u5f66, \u5e16\u4f50\u60a6\u7537. \u591a\u767a\u6027\u6ed1\u6db2\u80de\u708e\u306b\u3088\u308b\u8170\u690e\u7834\u58ca\u3092\u6765\u3057\u3001\u8170\u690e\u56fa\u5b9a\u8853\u3092\u8981\u3057\u305f\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1(RA). \u7b2c49\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u4e00\u822c\u6f14\u984c7 RA\u8170\u690e\u30fb\u4e0b\u80a2\u624b\u8853 O-7-1. 2015. (3\u670821\u65e5-22\u65e5\uff0822\u65e5\u767a\u8868\uff09, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u30a2\u30af\u30ed\u30b9\u798f\u5ca1)<\/li>\n<\/ol>\n

          \u3010\u305d\u306e\u4ed6\u3011<\/h4>\n
            \n
          1. \u9ad8\u57ce\u4e00\u90ce. \u8010\u6027\u83cc\u611f\u67d3\u75c7\u306e\u8a3a\u65ad\u3068\u6cbb\u7642\u3068\u4e88\u9632. \u5e73\u621026\u5e74\u5ea6\u611f\u67d3\u7ba1\u7406\u8a8d\u5b9a\u770b\u8b77\u5e2b\u6559\u80b2\u8ab2\u7a0b. \u5fae\u751f\u7269\u30fb\u611f\u67d3\u75c7\u5b66. 2014. (9\u670829\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u770c\u7acb\u770b\u8b77\u5927\u5b66)<\/li>\n
          2. \u5ca1\u5c71\u662d\u5f66. \u30d2\u30c8\u514d\u75ab\u4e0d\u5168\u30a6\u30a4\u30eb\u30b9\uff08human immunodeficiency virus: HIV)\u611f\u67d3\u75c7. \u5e73\u621026\u5e74\u5ea6\u611f\u67d3\u7ba1\u7406\u8a8d\u5b9a\u770b\u8b77\u5e2b\u6559\u80b2\u8ab2\u7a0b. \u5fae\u751f\u7269\u30fb\u611f\u67d3\u75c7\u5b66. 2014. (10\u67087\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u770c\u7acb\u770b\u8b77\u5927\u5b66)<\/li>\n
          3. \u9ad8\u57ce\u4e00\u90ce. \u5468\u8853\u671f\u306e\u6297\u83cc\u85ac\u306b\u3064\u3066. \u5e73\u621026\u5e74\u5ea6\u3000\u7b2c1\u56de\u9662\u5185\u30af\u30ea\u30cb\u30ab\u30eb\u30d1\u30b9\u5927\u4f1a. 2014. (10\u670821\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8)<\/li>\n
          4. \u6885\u5317\u90a6\u5f66. HTLV-1\u611f\u67d3\u7d30\u80de\u682a\u306e\u7523\u751f\u3059\u308b\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u7db2\u7f85\u7684\u89e3\u6790. \u5e73\u621026\u5e74\u5ea6\u539a\u751f\u52b4\u50cd\u79d1\u5b66\u7814\u7a76\u8cbb\u88dc\u52a9\u91d1(\u96e3\u6cbb\u6027\u75be\u60a3\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d)HTLV-1\u967d\u6027\u96e3\u6cbb\u6027\u75be\u60a3\u306e\u8a3a\u7642\u306e\u8cea\u3092\u9ad8\u3081\u308b\u305f\u3081\u306e\u30a8\u30d3\u30c7\u30f3\u30b9\u69cb\u7bc9\u3000\u51fa\u96f2\u73ed\u30fb\u5ca1\u5c71\u73ed\u5408\u540c\u73ed\u4f1a\u8b70. 2014. (12\u67085\u65e5, \u9e7f\u5150\u5cf6\u770c\u9e7f\u5150\u5cf6\u5e02, \u9e7f\u5150\u5cf6\u5927\u5b66\u533b\u5b66\u90e8\u5185\u9db4\u9675\u4f1a\u9928)<\/li>\n
          5. \u5ca1\u5c71\u662d\u5f66. \u30ea\u30a6\u30de\u30c1\u5c02\u9580\u533b\u3078\u306e\u4eca\u5f8c\u306e\u60c5\u5831\u63d0\u4f9b\u306b\u3064\u3044\u3066\uff1a\u5168\u56fd\u30a2\u30f3\u30b1\u30fc\u30c8\u8abf\u67fb\u7d50\u679c\u3092\u3075\u307e\u3048\u3066. \u5e73\u621026\u5e74\u5ea6\u539a\u751f\u52b4\u50cd\u79d1\u5b66\u7814\u7a76\u8cbb\u88dc\u52a9\u91d1(\u96e3\u6cbb\u6027\u75be\u60a3\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d)HTLV-1\u967d\u6027\u96e3\u6cbb\u6027\u75be\u60a3\u306e\u8a3a\u7642\u306e\u8cea\u3092\u9ad8\u3081\u308b\u305f\u3081\u306e\u30a8\u30d3\u30c7\u30f3\u30b9\u69cb\u7bc9\u3000\u51fa\u96f2\u73ed\u30fb\u5ca1\u5c71\u73ed\u5408\u540c\u73ed\u4f1a\u8b70. 2014. (12\u67085\u65e5, \u9e7f\u5150\u5cf6\u770c\u9e7f\u5150\u5cf6\u5e02, \u9e7f\u5150\u5cf6\u5927\u5b66\u533b\u5b66\u90e8\u5185\u9db4\u9675\u4f1a\u9928)<\/li>\n
          6. \u6885\u5317\u90a6\u5f66. HTLV-1\u30ad\u30e3\u30ea\u30a2\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u75c7\u4f8b\u691c\u8a0e\u4f1a\uff5e\u5bae\u5d0e\u30b3\u30db\u30fc\u30c8\uff5e. \u5e73\u621026\u5e74\u5ea6\u539a\u751f\u52b4\u50cd\u79d1\u5b66\u7814\u7a76\u8cbb\u88dc\u52a9\u91d1(\u96e3\u6cbb\u6027\u75be\u60a3\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d\uff09HTLV-1\u967d\u6027\u96e3\u6cbb\u6027\u75be\u60a3\u306e\u8a3a\u7642\u306e\u8cea\u3092\u9ad8\u3081\u308b\u305f\u3081\u306e\u30a8\u30d3\u30c7\u30f3\u30b9\u69cb\u7bc9\u3000\u5ca1\u5c71\u73ed\u75c7\u4f8b\u691c\u8a0e\u4f1a\u8b70. 2015 (1\u670824\u65e5, \u9577\u5d0e\u770c\u9577\u5d0e\u5e02, \u9577\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\u5916\u6765\u68df)<\/li>\n
          7. \u5ca1\u5c71\u662d\u5f66. HTLV-1\u967d\u6027\u96e3\u6cbb\u6027\u75be\u60a3\u306e\u8a3a\u7642\u306e\u8cea\u3092\u9ad8\u3081\u308b\u305f\u3081\u306e\u30a8\u30d3\u30c7\u30f3\u30b9\u69cb\u7bc9. \u5e73\u621026\u5e74\u5ea6\u539a\u751f\u52b4\u50cd\u79d1\u5b66\u7814\u7a76\u8cbb HTLV-1\u95a2\u9023\u75be\u60a3\u7814\u7a76\u9818\u57df\u7814\u7a76\u73ed\u5408\u540c\u767a\u8868\u4f1a. 2015. (2\u67087\u65e5, \u6771\u4eac\u90fd\u6e2f\u533a, \u6771\u4eac\u5927\u5b66\u533b\u79d1\u5b66\u7814\u7a76\u62401\u53f7\u9928\u8b1b\u5802)<\/li>\n
          8. \u5ca1\u5c71\u662d\u5f66. HTLV-1\u95a2\u9023\u5e0c\u5c11\u96e3\u6cbb\u6027\u75be\u60a3\u306b\u304a\u3051\u308b\u81e8\u5e8a\u7814\u7a76\u306e\u5168\u56fd\u5c55\u958b\u3068\u57fa\u76e4\u6574\u5099. \u5e73\u621026\u5e74\u5ea6\u539a\u751f\u52b4\u50cd\u79d1\u5b66\u7279\u5225\u7814\u7a76\u4e8b\u696d \u9032\u6357\u7ba1\u7406\u73ed(\u96e3\u6cbb\u6027\u75be\u60a3\u5b9f\u7528\u5316\u7814\u7a76\u30fb\u814e\u75be\u60a3\u5b9f\u7528\u5316\u7814\u7a76\u30fb\u6162\u6027\u306e\u75db\u307f\u89e3\u660e\u7814\u7a76)\u6210\u679c\u5831\u544a\u4f1a. 2015. (3\u670813\u65e5, \u6771\u4eac\u90fd\u4e2d\u592e\u533a, \u6771\u4eac\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30db\u30fc\u30eb)<\/li>\n<\/ol>\n

             <\/p>\n

            \n\"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a>\n<\/div>\n

            C. \u305d\u306e\u4ed6<\/h3>\n
              \n
            1. \u5ca1\u5c71\u662d\u5f66. \u30ea\u30a6\u30de\u30c1\u6cbb\u7642\u306b\u304a\u3051\u308b\u611f\u67d3\u75c7\u3078\u306e\u6ce8\u610f\u70b9. \u306f\u307e\u3086\u3046 no.48. 2014.(4\u670830\u65e5)<\/li>\n
            2. \u5ca1\u5c71\u662d\u5f66. \u611f\u67d3\u5236\u5fa1\u3068\u5fae\u751f\u7269\u691c\u67fb. THE MEDICAL&TEST JOURNAL. 2014. (11\u670811\u65e5)<\/li>\n
            3. \u9ad8\u57ce\u4e00\u90ce. \u5c4a\u51fa\u5236\u306b\u57fa\u3065\u3044\u305f\u30c0\u30d7\u30c8\u30de\u30a4\u30b7\u30f3\u306e\u4f7f\u7528\u72b6\u6cc1\u306e\u691c\u8a0e. \u8a18\u9332\u96c6 \u7b2c88\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a \u7b2c62\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a. 2014. (10\u6708)\u3000MSD(\u682a).<\/li>\n
            4. \u9ad8\u57ce\u4e00\u90ce. \uff62\u8a71\u984c\u306e\u611f\u67d3\u75c7\uff63\u30c7\u30f3\u30b0\u71b1\u306b\u3064\u3044\u3066. \u91ab\u53cb\u3057\u306e\u306e\u3081. 2014. (12\u67081\u65e5) \u5bae\u5d0e\u5e02\u90e1\u533b\u5e2b\u4f1a.<\/li>\n
            5. \u5ca1\u5c71\u662d\u5f66. \u65b0\u3057\u304f\u898b\u3064\u304b\u3063\u305f\u5bae\u5d0e\u306b\u591a\u3044\u611f\u67d3\u75c7\uff1a\u91cd\u75c7\u71b1\u6027\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7\u5019\u7fa4(Severe fever with thrombocytopenia syndrome: SFTS). \u65e5\u5dde\u91ab\u4e8b. 2015.(1\u670810\u65e5)<\/li>\n<\/ol>\n

              \u3010\u5b66\u4f1a\u4e3b\u50ac\u7b49\u3011<\/strong><\/p>\n

              \n\"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a>\n<\/div>\n

              D. \u7279\u8a31\u51fa\u9858<\/h3>\n

               <\/p>\n

              <\/p>\n

              –<\/p>\n

              \n\"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\"<\/a>\n<\/div>\n

              \u5185\u8a33\u6570\uff084\u670830\u65e5\u6642\u70b9\uff09
              \nA.\u8ad6\u6587\uff1a\u8457\u66f8(0)\u3001\u539f\u8457(7)\u3001\u75c7\u4f8b\u5831\u544a\uff08\u8ad6\u6587\uff09(7)\u3001\u7dcf\u8aac\uff081\uff09\u3000B.\u767a\u8868\uff1a\u5b66\u4f1a\u767a\u8868\uff0841\uff09\u3001\u305d\u306e\u4ed6\uff088\uff09 C.\u305d\u306e\u4ed6\uff085\uff09\u3000D.\u7279\u8a31\u51fa\u9858\uff080\uff09<\/p>\n","protected":false},"excerpt":{"rendered":"

              A. \u8ad6\u6587 \u3010\u8457\u66f8\u3011 \u3010\u539f\u8457\u3011 \u95a2\u826f\u4e8c, \u9577\u53cb\u5b89\u5f18, \u5c71\u53e3\u54f2\u6717, \u677e\u672c\u7d2b\u6717. \u5bae\u5d0e\u770c\u4e0b\u306b\u304a\u3051\u308b\u6210\u4eba\u5598\u606f\u60a3\u8005\u306b\u5bfe\u3057\u306610\u5e74\u9593\u9023\u7d9a\u3057\u3066\u884c\u3063\u305f\u5b9f\u614b\u8abf\u67fb \u2015\u5bae\u5d0e\u770c\u6c17\u7ba1\u652f\u5598\u606f\u30d5\u30a9\u30fc\u30e9\u30e0\u3067\u306e\u691c\u8a0e\u2015. \u30a2\u30ec\u30eb\u30ae\u30fc. 2014; 63: […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false},"categories":[9],"tags":[],"_links":{"self":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts\/265"}],"collection":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/comments?post=265"}],"version-history":[{"count":0,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts\/265\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/media?parent=265"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/categories?post=265"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/tags?post=265"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}